Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior.
about
Risk compensation in HIV prevention: Implications for vaccines, microbicides, and other biomedical HIV prevention technologiesPreexposure chemoprophylaxis for HIV prevention in men who have sex with menPreparing for HIV pre-exposure prophylaxis: lessons learned from post-exposure prophylaxisPractical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection: an editorial reviewPreconception care: preventing and treating infectionsTenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trialNo evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxisEmploying human rights frameworks to realize access to an HIV cure.The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study.The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention.Preexposure prophylaxis and predicted condom use among high-risk men who have sex with menEffects of messaging about multiple biomedical and behavioral HIV prevention methods on intentions to use among US MSM: results of an experimental messaging study.Availability of HIV postexposure prophylaxis services in Los Angeles CountyTrends in condom use and risk behaviours after sexual exposure to HIV: a seven-year observational study.Use of non-occupational post-exposure prophylaxis does not lead to an increase in high risk sex behaviors in men who have sex with men participating in the EXPLORE trialCurrent perspectives in HIV post-exposure prophylaxis.Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions.Will risk compensation accompany pre-exposure prophylaxis for HIV?A randomized noninferiority trial of standard versus enhanced risk reduction and adherence counseling for individuals receiving post-exposure prophylaxis following sexual exposures to HIVPre-exposure prophylaxis of HIV: A right way to go or a long way to go?Cost effectiveness of 'on demand' HIV pre-exposure prophylaxis for non-injection drug-using men who have sex with men in CanadaLongitudinal trends in HIV nonoccupational postexposure prophylaxis use at a Boston community health center between 1997 and 2013.Preventing human immunodeficiency virus infection among sexual assault survivors in Cape Town, South Africa: an observational studyGay and bisexual men's awareness and knowledge of treatment as prevention: findings from the Momentum Health Study in Vancouver, Canada.Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil.A novel combination HIV prevention strategy: post-exposure prophylaxis with contingency management for substance abuse treatment among methamphetamine-using men who have sex with men.Beyond informed consent: ethical considerations in the design and implementation of sexual and reproductive health research among adolescents.Antiretrovirals to prevent HIV infection: pre- and postexposure prophylaxis.Antiretroviral agents used by HIV-uninfected persons for prevention: pre- and postexposure prophylaxis.Preventive misconception and adolescents' knowledge about HIV vaccine trials.Perceptions of sexual risk compensation following posttrial HIV vaccine uptake among young South Africans.The impact of rapid HIV home test use with sexual partners on subsequent sexual behavior among men who have sex with menHIV medical providers' perceptions of the use of antiretroviral therapy as nonoccupational postexposure prophylaxis in 2 major metropolitan areas.Maraviroc concentrates in the cervicovaginal fluid and vaginal tissue of HIV-negative women.Biomedical approaches to HIV preventionAttitudes toward Web application supporting pharmacist-clinician comanagement of postexposure prophylaxis patients.High-risk Sexual Behavior is Associated with Post-Exposure Prophylaxis Non-adherence among Men who have Sex with Men Enrolled in a Combination Prevention InterventionDoes participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?Post-exposure prophylaxis following sexual exposure to HIV: a seven-year retrospective analysis in a regional centre.Overviewing a Nurse-Led, Community-Based HIV PEP Program: Applying the Extant Literature in Frontline Practice.
P2860
Q22252604-613C960C-439B-41EE-8E14-94A33E2DA361Q24612082-B87E09F4-0147-4D1B-98CB-6BAEF54D49E3Q26820865-B8DC85D1-DA30-4DAF-9024-5297B7D7CFDDQ26853055-C21A520E-0FBB-4E09-87AA-05612D535471Q26996391-8D4C2FA0-84FE-4D3C-B744-DA64949D54F1Q28469218-FD6C16A2-6D27-4AB3-88A5-D7C67D02DFB8Q28537713-A225B961-2097-4FDE-A54B-2E63A0DBD46CQ30381361-701A317E-9197-4366-968E-7FD7C3FC941CQ33332191-6077703D-B4EB-4218-B443-BD9A0B578F12Q33828458-68FDD338-F406-466D-8D63-412B41745EA2Q34012348-E4827EA1-91B1-4C05-B559-B2D70765926CQ34022092-90A76B53-F6B3-494B-801C-CC3937F5B2F1Q34071050-F0A3064E-1D40-4A53-9B16-8BB471EEF431Q34089535-2AA1F748-AB4A-4434-A214-693851CC4D41Q34152689-618857C2-1CEA-40B4-A9E3-707CFE51D1C9Q34434815-3DCAB544-ED07-45CE-9115-8962B2E4E31BQ34558034-8BB3E550-DEEC-4109-A8A9-1676A22F7DB1Q35020635-8F0C9659-D05B-42C1-BF3E-51AEBD70BBE7Q35031691-B7C73B03-A8A5-4AC6-977E-A09E0DC21EF8Q35033732-66C5A5F0-244B-4A7C-9FB6-077AB3D219F7Q35158119-FF3B183E-4B18-40A2-9720-1AFF5697E62DQ35696557-1DC29B7C-C698-47AF-BAC8-B0E5FBF8A012Q35916690-47ED5CAB-A772-495E-AEC2-1F7B972054FAQ35947588-41F3D352-53C1-4475-80D5-1908BED710A2Q35999008-35694419-7CFD-4D32-A9AC-B26F6F193E14Q36005091-4C0A320A-EE71-49B4-8CA2-12E6BBC256EFQ36297699-43199A9C-DCB4-4CF3-BF73-1B6B533B5484Q36597028-82932E2F-B6AD-4991-8C77-3CC4BBABEE84Q36873010-56F36617-F649-4501-AA7C-B10095B65E85Q36917016-56BE468B-F9DC-40F7-A996-3E33366C28DDQ37075094-6D89822C-05C0-448D-A1BA-FF637DE4569CQ37273885-82CFD38F-C9BB-4DDD-B4F9-D4C6EEF788E7Q37353723-06292DB8-C64E-470A-9338-6AFCBBCFE682Q37362444-FFCF1A0F-1DE2-4B6B-98B9-5BA22F2971BEQ37386665-77835013-C5D0-41E0-8F09-212BC93588BAQ37507747-654EEDF1-4A96-4DF4-A383-8B428308B16CQ37577527-2C736546-97B4-4781-8EDA-56397DE5DA53Q37617853-B66CE6D0-3AED-42A8-9E10-C88B816D03BFQ37850642-DDF74C90-B4CF-4861-8840-4C44038B33A5Q38201865-26661C24-4151-4DCD-9698-4A6E7EE78B08
P2860
Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Use of postexposure prophylaxi ...... creases in high-risk behavior.
@en
Use of postexposure prophylaxi ...... creases in high-risk behavior.
@nl
type
label
Use of postexposure prophylaxi ...... creases in high-risk behavior.
@en
Use of postexposure prophylaxi ...... creases in high-risk behavior.
@nl
prefLabel
Use of postexposure prophylaxi ...... creases in high-risk behavior.
@en
Use of postexposure prophylaxi ...... creases in high-risk behavior.
@nl
P2093
P1433
P1476
Use of postexposure prophylaxi ...... creases in high-risk behavior.
@en
P2093
James O Kahn
Jeffrey N Martin
Joshua D Bamberger
Karena Franses
Margaret A Chesney
Melissa R Krone
Michelle E Roland
Mitchell H Katz
Robert P Kohn
Thomas J Coates
P304
P356
10.1097/00002030-200403260-00010
P407
P577
2004-03-01T00:00:00Z